Ashley Van Zeeland, Ph.D.
Chief Technology Officer, Human Longevity, Inc.
Dr. Van Zeeland is the Chief Technology Officer for Human Longevity, Inc. and joined as part of the acquisition of Cypher Genomics, a leading cloud-based genome interpretation company, where she was co-founder and CEO. Prior to founding Cypher Genomics, she served as Director, Strategic Partnerships at the Scripps Translational Science Institute (STSI) where she focused on novel public-private partnerships to accelerate translational research. Before transitioning to her role as Director, Strategic Partnerships she was a research fellow in bioinformatics and statistical genetics at (STSI). She received a Ph.D. in Neuroscience from the University of California, Los Angeles and MBA from the University of California, San Diego.